The only FDA-approved injectable treatment for fecal incontinence, which is also cleared for commercialization in Europe. Fecal incontinence is a debilitating health problem afflicting about 2% of people worldwide and is four times more prevalent in women than men.
TIRED OF HAVING ACCIDENTS?
ASK YOUR DOCTOR ABOUT SOLESTA.
Solesta is a quick, nonsurgical treatment for the loss of bowel control, also known as bowel incontinence, or fecal incontinence (FI). Bowel incontinence is more common than you may think. Unfortunately, millions of people suffer every day from accidents and leaks. But Solesta can help. Treatment occurs in your doctor’s office and is proven to help significantly reduce accidents.
Ng K, Sivakumaran Y, Nassar N, Gladman MA. Fecal incontinence: community prevalence and associated factors–a systematic review. Dis Colon Rectum. 2015;58(12):1194-1209.
Irwin T, Snow AR, Orton TS, Elliot C. Endoscopic, ultrasonographic, and histologic descriptions of dextranomer/hyaluronic acid in a case of fecal incontinence. Case Reports in Pathology. 2018.
LOOKING FOR HELP?
FIND A DOCTOR NEAR YOU.
If you think you or someone you know may have bowel incontinence, there is no need to suffer in silence. There are a variety of specialists who can help. Our find a doctor tool is here to help you locate a specialist who can diagnose the condition and find the right treatment for you.
To find a doctor near you who can help treat bowel incontinence, please select the button below.
TRAINING AND CERTIFICATION
FOR ADMINISTERING SOLESTA.
Physicians must be experienced in performing anorectal procedures and trained and certified in order to administer Solesta. Completing training and certification will also allow you to participate in our Physician Finder, so patients can easily find you.
The health information contained herein is provided for educational purposes only and is not intended to replace discussions with a healthcare provider. All decisions regarding patient care must be made with a healthcare provider, considering the unique characteristics of the patient. The product information provided in this site is intended only for residents of the United States. The products discussed herein may have different product labeling in different countries.
Solesta should only be administered by physicians experienced in performing anorectal procedures and who have successfully completed a comprehensive training and certification program in the Solesta injection procedure.
Solesta is contraindicated in patients with active inflammatory bowel disease, immunodeficiency disorders or ongoing immunosuppressive therapy, previous radiation treatment to the pelvic area, significant mucosal or full thickness rectal prolapse, active proctitis or other infections in the anorectal region, anorectal atresia, tumors, or malformation, rectocele, or allergy to hyaluronic acid-based products.
Solesta is a registered trademark.